What is Tirzepatide?

Overview

Tirzepatide is a 39-amino-acid synthetic peptide engineered to activate both GIP and GLP-1 receptors. Studied for its compound effects on glucose-dependent insulin secretion, gastric emptying, and body-weight regulation.

Research areas

• Mechanism of action

• Preclinical research

• Safety profile

• Research applications

Published research

• Tirzepatide as Compared with Semaglutide for the…

  PMID 40353578 — PubMed

• A Post Hoc Analysis of the SURMOUNT-4 Trial

  PMID 41284285 — PubMed

• Body composition changes during weight reduction with…

  PMID 39996356 — PubMed

• Results from the SURMOUNT-3 phase 3 randomized trial

  PMID 40365662 — PubMed

• Tirzepatide for the treatment of obesity: Rationale and…

  PMID 36478180 — PubMed

• Tirzepatide Once Weekly for the Treatment of Obesity

  PMID 35658024 — PubMed

Storage & handling

Lyophilized Tirzepatideis stored at –20 °C protected from light. Once reconstituted with bacteriostatic water, store at 2–8 °C and use within 30 days for maximum stability.

Frequently asked questions

What is Tirzepatide?

Tirzepatide (Tirzepatide) is a research compound studied in the area of metabolic. Dual GIP and GLP-1 receptor agonist used in research of metabolic regulation, insulin sensitivity, and adiposity.

What is the CAS number of Tirzepatide?

The CAS registry number of Tirzepatide is 2023788-19-2.

How should Tirzepatide be stored?

Lyophilized Tirzepatide should be stored at –20 °C protected from light. Once reconstituted with bacteriostatic water, store at 2–8 °C and use within 30 days for maximum stability.

How is the purity of Tirzepatide verified?

Every Woosh Labs batch of Tirzepatide is independently tested by third-party HPLC and mass spectrometry, with a batch-specific Certificate of Analysis published verifying ≥99% purity.

Is Tirzepatide for human use?

No. Tirzepatide sold by Woosh Labs is strictly for in-vitro laboratory research by qualified professionals. It is not for human or veterinary use of any kind.